z-logo
open-access-imgOpen Access
PS101. Oral Ketamine for Treatment Resistant Major Depression – A double blind randomized controlled trial
Author(s) -
Yoav Domany,
Maya BleichCohen,
Nadav Stoppelman,
Talma Hendler,
Ricardo Tarrasch,
Shaul Schreiber,
Roi Meidan,
Haggai Sharon
Publication year - 2016
Publication title -
the international journal of neuropsychopharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.897
H-Index - 107
eISSN - 1469-5111
pISSN - 1461-1457
DOI - 10.1093/ijnp/pyw043.101
Subject(s) - randomized controlled trial , double blind , treatment resistant depression , depression (economics) , ketamine , medicine , psychiatry , psychology , major depressive disorder , alternative medicine , placebo , mood , pathology , economics , macroeconomics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom